Author(s): Emily James, Suseem Sundaram, Renjitham

Email(s): emilyjames2001@gmail.com , srsuseem@vit.ac.in

DOI: 10.52711/0974-360X.2023.00195   

Address: Emily James, Suseem Sundaram, Renjitham*
School of Advanced Sciences (SAS), Vellore Institute of Technology (VIT), Vellore
*Corresponding Author

Published In:   Volume - 16,      Issue - 3,     Year - 2023


ABSTRACT:
Rheumatoid Arthritis is a chronic autoimmune condition in which the patient experiences pain, joint immobility which in some instance can also lead to disability, and thus difficulty in carrying out various activities of daily living. It is a natural consequence that patients may experience varying degrees of depressive symptoms and fatigue. Aim and Objectives: In our study, it is our objective to find out the prevalence of depression, its severity and its correlation with disease activity, pain and inflammatory markers like ESR. We also attempted to quantify the fatigue using the MAF scale by calculating the GFI (Global Fatigue Index) and its prevalence in remission vs non remission patients. Study design: The study is a cross-sectional observational study of consecutive patients with a diagnosis of RA as per EULAR 2020 criteria. The patients were interviewed using standard questionnaires MAF (multidimensional assessment of fatigue questionnaire) and PHQ9 (Patient Health Questionnaire 9). Tools used in the study: Fatigue was measured by using MAF (Multidimensional Assessment of Fatigue). Depression is measured using the PHQ9 questionnaire. Results: The population studied was found to have a prevalence of 33.5% depression. The patients’ mean age was 52.45?10.53 years and disease duration 8.02?6.22 years. Their mean DAS28 was 2.96?1.1. The mean PHQ-9 score was 3.99?3.5., mild (26%), moderate (5.5%), moderately severe (1.5%) and severe (0.5%) degrees. Correlation of PHQ9 scores with DAS, VAS and ESR was done to see if there is a relation of depression to any of the clinical outcomes. It was found that depression had a positive correlation with disease activity score DAS 28 (coefficient of correlation 0.167, p = 0.018), VAS pain scores (coefficient = 0.361, p < 0.001) as well as ESR (coefficient = 0.217, and p = 0.002). Fatigue was evaluated using the MAF which gave the Global Fatigue Index (GFI). The mean MAF score was 8.62?3.33. 78% of patients had fatigue in the level (0-10), 20.5% in the (10-20) level and 1.5% in the (20-30) level. Statistical test for comparison between groups using t test was found to be significant with p value 0.034. Conclusion: Our study on both depression and fatigue once again emphasises the need for rheumatologists especially in the Indian scenario to address them in their routine clinical practice. There should be regular screening for these conditions during the patient visits similar to other risk factors screening in RA.


Cite this article:
Emily James, Suseem Sundaram, Renjitham. Depression and Fatigue in Rheumatoid Arthritis- A Study in Southern India. Research Journal of Pharmacy and Technology. 2023; 16(3):1175-9. doi: 10.52711/0974-360X.2023.00195

Cite(Electronic):
Emily James, Suseem Sundaram, Renjitham. Depression and Fatigue in Rheumatoid Arthritis- A Study in Southern India. Research Journal of Pharmacy and Technology. 2023; 16(3):1175-9. doi: 10.52711/0974-360X.2023.00195   Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-3-31


REFERENCE:
1.    Khan M. Y, Aziz I, Ahmad I, Roy M, VermaV.K. A Natural Cure to Arthritis by Phytomedicines- A Review. Asian J. Res. Pharm. Sci. 5(4): 2015; 216-220.
2.    Thankachan J P, Bhattacharya C, A Study to Assess Depression and Coping Strategies among Dermatological Patients in a Selected Hospital in Mangalore. Asian J. Nur. Edu. and Research 5(2): April-June 2015; 185-190. doi: 10.5958/2349-2996.2015.00038.5)
3.    Thomas D, Lobo D, Effectiveness of exercise Programme on Fatigue among Patients Undergoing Cancer Treatment in Selected Hospitals, Mangaluru. Asian J. Nursing Education and Research. 2018; 8(1): 99-105.
4.    Kirwan JR, Hewlett S. Patient perspective: reasons and methods for measuring fatigue in rheumatoid arthritis. J Rheumatol 2007; 34:1171-3
5.    Kirwan JR, Hewlett SE, Heiberg T, Hughes RA, Carr M, Hehir M, Kvien TK, Minnock P, Newman SP, Quest EM, Taal E, Wale J. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis — progress at OMERACT 7 J Rheumatol 2005; 32:2250-6. PMID: 16265712.
6.    Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford). 2006 Jul;45(7):885-9. doi: 10.1093/rheumatology/kel021. E-pub 2006 Jan 31. PMID: 16449363 doi: 10.1093/rheumatology/kel021. Epub 2006 Jan 31.
7.    Nikolaus S, Bode C, Taal E, van de Laar MA. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken). 2013 Jul;65(7):1128-46. doi: 10.1002/acr.21949.
8.    Zielinski Mark R., Systrom David M., Rose Noel R, Fatigue, sleep, and autoimmune and related disorders. Front Immunol 2019; 10:1827 https:doi.org/10.3389/fimmu.2019.01827
9.    Pope JE et al, Management of Fatigue in Rheumatoid Arthritis. RMD Open 2020;6: e001084. doi:10.1136/ rmdope-2019-001084.
10.    Nerurkar L, Siebert S, McInnes IB, Cavanagh J. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry. 2019 Feb;6(2):164-173. doi: 10.1016/S2215-0366(18)30255-4. Epub 2018 Oct
11.    Fragoulis GE, Cavanagh J, Tindell A, et al. Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease features. RMD Open 2020; 6:e001376. doi:10.1136/ rmdopen-2020-001376.
12.    Schrepf A, Kaplan CM, Ichesco E, Larkin T, Harte SE, Harris RE, Murray AD, Waiter GD, Clauw DJ, Basu N. A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis. Nat Commun. 2018 Jun 8; 9(1):2243. doi: 10.1038/s41467-018-04648-0
13.    Sheeba Chellappan, Rajamanickam Rajkumar, Merlin Jeyapal. Cancer Pain Management: Teaching Program for Terminally ill Cancer Patients. Asian J. Nur. Edu. and Research.2017; 7(2): 151-154. doi: 10.5958/2349-2996.2017.00030.1
14.    Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, Wierød A, Kalstad S, Rødevand E, Krøll F, Haugeberg G, Kvien TK. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017 Nov;76(11):1906-1910. doi: 10.1136/annrheumdis-2017-211284.
15.    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
16.    Megha S. Kulkarni, Gagan Deep S. V. Detection of Arthritis by Erythrocyte Sedimentation Rate (ESR) Test – A Review. Res. J. Pharmacology and Pharmacodynamics.2020; 12(4):177-180. DOI:10.5958/2321-5836.2020.00032.4
17.    Srivastava S, Patel, S.J. Daharwal, Deependra Singh, Manju Singh. Rheumatoid Arthritis: An Autoimmune Disease Prevalent in Females. Research J. Pharm. and Tech. 9(2): Feb., 2016; Page 170-172. doi: 10.5958/0974-360X.2016.00030.5S
18.    Arvind J, Sarang J, Amit J. A Systematic Review of the Incidence, Prevalence Work Limitations of Osteoarthritis, Rheumatoid Arthritis, Back Pain, Multiple Sclerosis. Res. J. Pharmacology and Pharmacodynamics.2020; 12(3):103-110. doi: 10.5958/2321-5836.2020.00020.
19.    Margaretten M, Yelin E, Imboden J, Graf J, Barton J, Katz P, Julian L. Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis. Arthritis Rheum. 2009 Nov 15;61(11):1586-91. doi: 10.1002/art.24822.
20.    Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013 Dec;52(12):2136-48. doi: 10.1093/rheumatology/ket169. Epub 2013 Sep 3.
21.    Tripathi N, Kumar MB. A Study to assess the Quality of life among Persons living with Hypertension, Diabetes Mellitus and Arthritis in selected Village of Ludhiana, Punjab. Int. J. Nur. Edu. and Research. 2018; 6(4): 379-382. doi: 10.5958/2454-2660.2018.00092.3
22.    Overman CL, Bossema ER, van Middendorp H, Wijngaards-de Meij L, Verstappen SM, Bulder M, Jacobs JW, Bijlsma JW, Geenen R. The prospective association between psychological distress and disease activity in rheumatoid arthritis: a multilevel regression analysis. Ann Rheum Dis. 2012 Feb;71(2):192-7. doi: 10.1136/annrheumdis-2011-200338. Epub 2011 Sep 14.
23.    Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa TA, Tokudome S, Ishiguro N. Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Rheum. 2009 Aug 15;61(8):1018-24. doi: 10.1002/art.24647.
24.    B. Premkumar. Antioxidant Defense and Disease activity in Rheumatoid Arthritis. Research J. Pharm. and Tech 2018; 11(5):1810-1814.  doi: 10.5958/0974-360X.2018.00336.0
25.    Kavitha. D, Kalpana. K, Tamilselvi. S, MekalaC. Comparative study to Evaluate the effectiveness of progressive muscle relaxation techniques versus guided imagery therapy on fatigue and quality of life among patients with head and neck cancer who are undergoing chemotherapy in selected hospital at Erode. Int. J. of Advances in Nur. Management. 2021; 9(1):72-77. https://doi.org/10.5958/2454-2652.2021.00019.6

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available